These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1263076)

  • 1. Platinum complexes: a new class of antineoplastic agents.
    Leh FK; Wolf W
    J Pharm Sci; 1976 Mar; 65(3):315-28. PubMed ID: 1263076
    [No Abstract]   [Full Text] [Related]  

  • 2. New platinum complexes with anti-tumour activity.
    Connors TA; Jones M; Ross WC; Braddock PD; Khokhar AR; Tobe ML
    Chem Biol Interact; 1972 Nov; 5(6):415-24. PubMed ID: 4652593
    [No Abstract]   [Full Text] [Related]  

  • 3. A proposed mode of action of antitumor platinum compounds based upon studies with cis-dichloro-((G- 3 H)dipyridine)platinum(II).
    Howle JA; Gale GR; Smith AB
    Biochem Pharmacol; 1972 May; 21(10):1465-75. PubMed ID: 5029426
    [No Abstract]   [Full Text] [Related]  

  • 4. Antileukemic properties of organoplatinum complexes.
    Meischen SJ; Gale GR; Lake LM; Frangakis CJ; Rosenblum MG; Walker EM; Atkins LM; Smith AB
    J Natl Cancer Inst; 1976 Oct; 57(4):841-5. PubMed ID: 1003531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
    Miernicka M; Szulawska A; Czyz M; Lorenz IP; Mayer P; Karwowski B; Budzisz E
    J Inorg Biochem; 2008 Feb; 102(2):157-65. PubMed ID: 17868889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non platinum metal complexes as anti-cancer drugs.
    Ott I; Gust R
    Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum compounds in cancer chemotherapy.
    Pouskouleli G; Kourounakis P
    Biochem Exp Biol; 1980; 16(2):191-212. PubMed ID: 6753877
    [No Abstract]   [Full Text] [Related]  

  • 8. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
    Lee K; Tashiro T; Noji M
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileukemic properties of combinations of radiation and malonato(1,2-diaminocyclohexane) platinum(ii) (NSC-224964).
    Morris CR; Blackwell LH; Loveless VS
    J Med; 1977; 8(3-4):253-9. PubMed ID: 267715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
    Babak MV; Ang WH
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.
    Komeda S
    Metallomics; 2011 Jul; 3(7):650-5. PubMed ID: 21519596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and tumor inhibiting activity of lanthanum (III) complexes with some 1-aminocycloalkancarboxylic acids.
    Kovachev TB; Ivanov DS; Buyukliev RT; Konstantinov SM; Karaivanova MC
    Pharmazie; 1996 Jan; 51(1):25-7. PubMed ID: 8999429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
    Keppler BK; Diez A; Seifried V
    Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchogenic carcinoma: new drugs available for study.
    Slavik M; Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):265-9. PubMed ID: 4125744
    [No Abstract]   [Full Text] [Related]  

  • 16. A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468.
    Mandal S; Bérubé G; Asselin E; Richardson VJ; Church JG; Bridson J; Pham TN; Pramanik SK; Mandal SK
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2139-45. PubMed ID: 17321743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of triazolium-bis(triazole)-tetrachlororuthenate (III) and bistriazolium-triazolepentachlororuthenate (III). Two representatives of a new class of inorganic antitumor agents.
    Keppler BK; Balzer W; Seifried V
    Arzneimittelforschung; 1987 Jul; 37(7):770-1. PubMed ID: 3675670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
    Fortin S; Brasseur K; Morin N; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Oct; 68():433-43. PubMed ID: 23994871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of seleno- and thioguanine-platinum(II) complexes and their antitumor activity in mice.
    Maeda M; Abiko N; Sasaki T
    J Med Chem; 1981 Feb; 24(2):167-9. PubMed ID: 7205884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor properties of organometallic metallocene complexes of tin and germanium.
    Köpf-Maier P; Janiak C; Schumann H
    J Cancer Res Clin Oncol; 1988; 114(5):502-6. PubMed ID: 3182909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.